Greece Fact Sheet
In comparison to other countries heavily affected by the Eurozone debt crisis, Greece is still struggling to find its feet.
Greece fares poorly on almost all macroeconomic indicators compared to the Euro area since the start of the recession.
The Greek pharma market has shrunk in value significantly from 2009 to 2015.
Public pharmaceutical expenditure has also shrunk year-on-year since 2009, with an increasing amount of clawbacks and rebates.
The Top Ten pharmaceutical companies in Greece are led by global heavyweights Pfizer, Novartis, and Sanofi.
Greece has by far the highest number of pharmacies per 100,000 inhabitants in the EU 27 - 99 compared to just six in Denmark.
The size of the Greek population is set to shrink by almost two million by 2050, with the percentage of the population aged 65 and over set to increase from 20.7 percent to 33.9 percent.
Diseases of the circulatory system remain the most significant causes of death in Greece.
In comparison to other countries heavily affected by the Eurozone debt crisis, Greece is still struggling to find its feet.
Greece fares poorly on almost all macroeconomic indicators compared to the Euro area since the start of the recession.
The Greek pharma market has shrunk in value significantly from 2009 to 2015.
Public pharmaceutical expenditure has also shrunk year-on-year since 2009, with an increasing amount of clawbacks and rebates.
The Top Ten pharmaceutical companies in Greece are led by global heavyweights Pfizer, Novartis, and Sanofi.
Greece has by far the highest number of pharmacies per 100,000 inhabitants in the EU 27 - 99 compared to just six in Denmark.
The size of the Greek population is set to shrink by almost two million by 2050, with the percentage of the population aged 65 and over set to increase from 20.7 percent to 33.9 percent.
Diseases of the circulatory system remain the most significant causes of death in Greece.
